Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors

BACKGROUND: BRAF V600 mutant circulating cell-free tumor DNA (BRAF V600mut ctDNA) could serve as a specific biomarker in patients with BRAF V600 mutant melanoma. We analyzed the value of BRAF V600mut ctDNA from plasma as a monitoring tool for advanced melanoma patients treated with BRAF/MEK inhibito...

詳細記述

保存先:
書誌詳細
出版年:J Transl Med
主要な著者: Schreuer, Max, Meersseman, Geert, Van Den Herrewegen, Sari, Jansen, Yanina, Chevolet, Ines, Bott, Ambre, Wilgenhof, Sofie, Seremet, Teofila, Jacobs, Bart, Buyl, Ronald, Maertens, Geert, Neyns, Bart
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2016
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4837559/
https://ncbi.nlm.nih.gov/pubmed/27095081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-0852-6
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料